1994
DOI: 10.1159/000247165
|View full text |Cite
|
Sign up to set email alerts
|

Treatment of Port-Wine Stains with the 585-nm Flashlamp-Pulsed Tunable Dye Laser: A Study of 74 Patients

Abstract: Over 20 months, we have treated 74 patients (59 children less than 12 years of age) with port-wine stains (PWS) using a 585-nm flashlamp-pulsed dye laser (SPTL-1, Candela Corp., Wayland, Mass., USA) after topical anesthesia with EmlaTM cream. A 5-point reference color scale was used to evaluate the results. 45 patients had at least one treatment on the entire surface of the lesion. A mean of 88 impacts per session was delivered. There was a significant decrease in color in around two thirds of the c… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
21
2
1

Year Published

1998
1998
2010
2010

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 41 publications
(24 citation statements)
references
References 14 publications
0
21
2
1
Order By: Relevance
“…Although transitory adverse effects were rare in the Goldman/Eckhouse study [16] (blisters 2%, crusting 0.4%, hypopigmentation 3%, hyperpigmentation 4%), Green [44] observed a higher incidence of blisters (42%), hypopigmentation (20%), hyperpigmentation (50%) and scarring (21% vs. 0.5% in Goldman/Eckhouse study) using IPLS for treatment of leg telangiectases. In comparison, FLPDL caused post-purpura pig- mentation reported at a frequency of 9 to 57% [9,34,[45][46][47][48] and post-inflammatory hypopigmentation in 2% to 10% [34,47,[49][50][51]. The success rate with venous malformations, combined with a relatively low incidence of side effects, makes IPLS a useful alternative for adjunctive or primary treatment of venous malformations.…”
Section: Discussionmentioning
confidence: 99%
“…Although transitory adverse effects were rare in the Goldman/Eckhouse study [16] (blisters 2%, crusting 0.4%, hypopigmentation 3%, hyperpigmentation 4%), Green [44] observed a higher incidence of blisters (42%), hypopigmentation (20%), hyperpigmentation (50%) and scarring (21% vs. 0.5% in Goldman/Eckhouse study) using IPLS for treatment of leg telangiectases. In comparison, FLPDL caused post-purpura pig- mentation reported at a frequency of 9 to 57% [9,34,[45][46][47][48] and post-inflammatory hypopigmentation in 2% to 10% [34,47,[49][50][51]. The success rate with venous malformations, combined with a relatively low incidence of side effects, makes IPLS a useful alternative for adjunctive or primary treatment of venous malformations.…”
Section: Discussionmentioning
confidence: 99%
“…24,25 In the treatment of PWSs, FLPDL caused comparatively frequent postinflammatory hyperpigmentation reported at a frequency of 9% to 57 % 5,6,32,35,[46][47][48] and postinflammatory hypopigmentation in 2% to 10 %. 3,4,6,16,46 Hyperpigmentation and hypopigmentation were also the most common transient side effects of the long-pulsed FLPDL treatment of leg veins. 17,18 The success rate with PWSs, particularly with FLPDL-resistant dark types, combined with a relatively low incidence of side effects, makes IPLS a useful alternative for adjunctive or primary treatment of PWSs.…”
Section: Commentmentioning
confidence: 99%
“…Several prognostic criteria have been put forward to assist in predicting treatment outcome, as PWS color, patient’s age and PWS site [2, 9, 10]. However, it is clear that it is necessary to know in advance the characteristics of the vascular pattern, such as the vessel depth, the vessel diameter and the thickness of the vessel wall.…”
Section: Introductionmentioning
confidence: 99%